CYNTHIA MILLER: Open Payments
NPI 1497790992 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$60,819 in 178 payments from 11 companies in 2025. Trend: 2023 $137,220 · 2024 $51,465 · 2025 $60,819
Speaker / faculty: $47,820Travel & lodging: $6,108Consulting: $3,875Food & beverage: $3,016
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 78 | $36,163 |
| Vanda Pharmaceuticals Inc. | 39 | $14,044 |
| ABBVIE INC. | 31 | $9,958 |
| Axsome Therapeutics, Inc. | 14 | $356 |
| Alkermes, Inc. | 6 | $109 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18 |
Products named: CAPLYTA, FANAPT, VRAYLAR, Auvelity, LYBALVI, REXULTI, TRINTELLIX, INGREZZA.
Industry payments across TN — which companies pay providers there.
